CureVac-GSK coronavirus variant vaccine generates good immune response in rats
* CureVac, GSK announced collaboration in Feb* New mRNA specifically targets coronavirus variants* GSK looking for reset after Sanofi, Clover setbacksBy Alistair SmoutLONDON, May 13 (Reuters) - A second-generation COVID-19 vaccine developed by CureV...
Read more